HER2-Low NewsLatest News On HER2-Low Trastuzumab Deruxtecan Shows Promise for HR+/HER2-Low/Ultra-Low Metastatic Breast Cancer12/19/2024 4:55 AM Q&A: HER2- Low Breast Cancer Pathophysiology and Evidence-Based Treatment Approaches10/17/2024 12:49 PM New Trials in Breast Cancer: Could Your Patient Benefit?9/16/2024 7:43 AM New ADC Results Mixed in Metastatic Breast Cancer7/10/2024 3:50 AM ASCO 2024: How to Best Use New Breast Cancer Data6/20/2024 12:46 PM T-DXd Moves Toward the Front Line for HER2-Low Metastatic BC6/11/2024 5:15 AM ASCO 2024: What's New in Breast Cancer Research?6/6/2024 10:08 AM
